Cargando…

Osteosarcoma: a comprehensive review

Osteosarcoma (OS) is a relatively rare tumor of bone with a worldwide incidence of 3.4 cases per million people per year. For most of the twentieth century, five-year survival rates for classic OS were very low. In the 1970s, the introduction of adjuvant chemotherapy in the treatment of OS increased...

Descripción completa

Detalles Bibliográficos
Autores principales: Misaghi, Amirhossein, Goldin, Amanda, Awad, Moayd, Kulidjian, Anna A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: EDP Sciences 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5890448/
https://www.ncbi.nlm.nih.gov/pubmed/29629690
http://dx.doi.org/10.1051/sicotj/2017028
_version_ 1783312872656338944
author Misaghi, Amirhossein
Goldin, Amanda
Awad, Moayd
Kulidjian, Anna A
author_facet Misaghi, Amirhossein
Goldin, Amanda
Awad, Moayd
Kulidjian, Anna A
author_sort Misaghi, Amirhossein
collection PubMed
description Osteosarcoma (OS) is a relatively rare tumor of bone with a worldwide incidence of 3.4 cases per million people per year. For most of the twentieth century, five-year survival rates for classic OS were very low. In the 1970s, the introduction of adjuvant chemotherapy in the treatment of OS increased survival rates dramatically. The current article reviews the various types of OS and analyzes the clinical and histological features. We also examine historical and current literature to present a succinct review of methods for diagnosis and staging, as well as treatment, and we also discuss some of the future directions of treatment.
format Online
Article
Text
id pubmed-5890448
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher EDP Sciences
record_format MEDLINE/PubMed
spelling pubmed-58904482018-04-17 Osteosarcoma: a comprehensive review Misaghi, Amirhossein Goldin, Amanda Awad, Moayd Kulidjian, Anna A SICOT J Review Article Osteosarcoma (OS) is a relatively rare tumor of bone with a worldwide incidence of 3.4 cases per million people per year. For most of the twentieth century, five-year survival rates for classic OS were very low. In the 1970s, the introduction of adjuvant chemotherapy in the treatment of OS increased survival rates dramatically. The current article reviews the various types of OS and analyzes the clinical and histological features. We also examine historical and current literature to present a succinct review of methods for diagnosis and staging, as well as treatment, and we also discuss some of the future directions of treatment. EDP Sciences 2018-04-09 /pmc/articles/PMC5890448/ /pubmed/29629690 http://dx.doi.org/10.1051/sicotj/2017028 Text en © The Authors, published by EDP Sciences, 2018 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Misaghi, Amirhossein
Goldin, Amanda
Awad, Moayd
Kulidjian, Anna A
Osteosarcoma: a comprehensive review
title Osteosarcoma: a comprehensive review
title_full Osteosarcoma: a comprehensive review
title_fullStr Osteosarcoma: a comprehensive review
title_full_unstemmed Osteosarcoma: a comprehensive review
title_short Osteosarcoma: a comprehensive review
title_sort osteosarcoma: a comprehensive review
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5890448/
https://www.ncbi.nlm.nih.gov/pubmed/29629690
http://dx.doi.org/10.1051/sicotj/2017028
work_keys_str_mv AT misaghiamirhossein osteosarcomaacomprehensivereview
AT goldinamanda osteosarcomaacomprehensivereview
AT awadmoayd osteosarcomaacomprehensivereview
AT kulidjianannaa osteosarcomaacomprehensivereview